Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2022

01-04-2022 | Ulcerative Colitis | Original Article

Baseline Histological Findings Do Not Predict the Risk of Subsequent Extension in Patients with Limited Ulcerative Colitis

Authors: Yansheng Hao, Clara Yzet, Russell B. McBride, Aryeh Stock, Elisa Tiratterra, Antonietta D’Errico, Andrea Belluzzi, Eleonora Scaioli, Paolo Gionchetti, Giulia Roda, Ryan Ungaro, Jean-Frederic Colombel, Noam Harpaz, Huaibin Mabel Ko

Published in: Digestive Diseases and Sciences | Issue 4/2022

Login to get access

Abstract

Background

Among patients with limited ulcerative colitis (UC), 30% ultimately extend to pancolitis and are at increased risk of adverse clinical outcomes. Risk of endoscopic extension has been found to correlate with clinical features such as early age of onset.

Aims

We sought to determine whether histologic features correlate with disease extension.

Methods

The study population consisted of 40 patients with UC from two large academic centers diagnosed between 2006 and 2017. Eligible cases had a diagnosis of endoscopically limited UC (Montreal E1 or E2) at baseline and ≥ 2 subsequent endoscopic examinations with biopsies. Severity of inflammation was scored using both the Mount Sinai Activity Index and Nancy Histological Index.

Results

Patients were divided into two cohorts: those who progressed to pancolitis (Montreal E3) were defined as “Extenders” (n = 21), whereas “Non-extenders” (n = 19) were cases without progression in the follow-up period. The median follow-up time was 58.4 months. The histologic scores in the endoscopically involved mucosa of the index biopsies were not associated with subsequent extension of disease, overall. However, among extender cohort, the index histology scores correlated with biopsy scores at extension (r = 0.455, P = 0.044) and index severity was associated with a shorter time to extension (r =  − 0.611, P = 0.003). Furthermore, female patients had a shorter time to extension (P = 0.013).

Conclusions

Histological severity of limited UC is not an independent predictor of extension in UC. However, among patients who subsequently extend, severe inflammation at baseline correlates with shorter progression time and severe inflammation when extension occurs. Patients with limited UC but severe histologic inflammation may warrant more frequent endoscopic surveillance.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ungaro R, Mehandru S, Allen PB et al. Ulcerative colitis. The Lancet 2017;389:1756–1770.CrossRef Ungaro R, Mehandru S, Allen PB et al. Ulcerative colitis. The Lancet 2017;389:1756–1770.CrossRef
2.
go back to reference Magro F, Rodrigues A, Vieira AI et al. Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts. Inflamm Bowel Dis 2012;18:573–583.CrossRef Magro F, Rodrigues A, Vieira AI et al. Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts. Inflamm Bowel Dis 2012;18:573–583.CrossRef
3.
go back to reference Roda G, Narula N, Pinotti R et al. Systematic review with meta-analysis: proximal disease extension in limited ulcerative colitis. Aliment Pharmacol Ther 2017;45:1481–1492.CrossRef Roda G, Narula N, Pinotti R et al. Systematic review with meta-analysis: proximal disease extension in limited ulcerative colitis. Aliment Pharmacol Ther 2017;45:1481–1492.CrossRef
4.
go back to reference Solberg IC, Lygren I, Jahnsen J et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol 2009;44:431–440.CrossRef Solberg IC, Lygren I, Jahnsen J et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol 2009;44:431–440.CrossRef
5.
go back to reference Gupta RB, Harpaz N, Itzkowitz S et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007;133:1099–1105.CrossRef Gupta RB, Harpaz N, Itzkowitz S et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007;133:1099–1105.CrossRef
6.
go back to reference Colman RJ, Rubin DT. Histological inflammation increases the risk of colorectal neoplasia in ulcerative colitis: a systematic review. Intest Res 2016;14:202.CrossRef Colman RJ, Rubin DT. Histological inflammation increases the risk of colorectal neoplasia in ulcerative colitis: a systematic review. Intest Res 2016;14:202.CrossRef
7.
go back to reference Etchevers MJ, Aceituno M, García-Bosch O et al. Risk factors and characteristics of extent progression in ulcerative colitis. Inflamm Bowel Dis 2009;15:1320–1325.CrossRef Etchevers MJ, Aceituno M, García-Bosch O et al. Risk factors and characteristics of extent progression in ulcerative colitis. Inflamm Bowel Dis 2009;15:1320–1325.CrossRef
8.
go back to reference Bryant RV, Burger DC, Delo J et al. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up. Gut 2016;65:408–414.CrossRef Bryant RV, Burger DC, Delo J et al. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up. Gut 2016;65:408–414.CrossRef
9.
go back to reference Zenlea T, Yee EU, Rosenberg L et al. Histology grade is independently associated with relapse risk in patients with ulcerative colitis in clinical remission: a prospective study. Am J Gastroenterol 2016;111:685–690.CrossRef Zenlea T, Yee EU, Rosenberg L et al. Histology grade is independently associated with relapse risk in patients with ulcerative colitis in clinical remission: a prospective study. Am J Gastroenterol 2016;111:685–690.CrossRef
10.
go back to reference Magro F, Lopes J, Borralho P et al. Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levels. Gut 2019;68:594–603.CrossRef Magro F, Lopes J, Borralho P et al. Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levels. Gut 2019;68:594–603.CrossRef
11.
go back to reference Marchal-Bressenot A, Salleron J, Boulagnon-Rombi C et al. Development and validation of the Nancy histological index for UC. Gut 2017;66:43–49.CrossRef Marchal-Bressenot A, Salleron J, Boulagnon-Rombi C et al. Development and validation of the Nancy histological index for UC. Gut 2017;66:43–49.CrossRef
12.
go back to reference Theede K, Holck S, Ibsen P et al. Level of fecalcalprotectin correlates with endoscopic and histologic inflammation and identifies patients with mucosal healing in ulcerative colitis. Clin Gastroenterol Hepatol 2015;13:e1. Theede K, Holck S, Ibsen P et al. Level of fecalcalprotectin correlates with endoscopic and histologic inflammation and identifies patients with mucosal healing in ulcerative colitis. Clin Gastroenterol Hepatol 2015;13:e1.
13.
go back to reference Burisch J, Ungaro R, Vind I et al. Proximal disease extension in patients with limited ulcerative colitis: a danish population-based inception cohort. J Crohns Colitis 2017;11:1200–1204.CrossRef Burisch J, Ungaro R, Vind I et al. Proximal disease extension in patients with limited ulcerative colitis: a danish population-based inception cohort. J Crohns Colitis 2017;11:1200–1204.CrossRef
14.
go back to reference Meucci G, Vecchi M, Astegiano M et al. The natural history of ulcerative proctitis: a multicenter, retrospective study. Am J Gastroenterol 2000;95:469–473.CrossRef Meucci G, Vecchi M, Astegiano M et al. The natural history of ulcerative proctitis: a multicenter, retrospective study. Am J Gastroenterol 2000;95:469–473.CrossRef
15.
go back to reference Park SH, Kim YM, Yang S-K et al. Clinical features and natural history of ulcerative colitis in Korea. Inflamm Bowel Dis 2007;13:278–283.CrossRef Park SH, Kim YM, Yang S-K et al. Clinical features and natural history of ulcerative colitis in Korea. Inflamm Bowel Dis 2007;13:278–283.CrossRef
16.
go back to reference Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 1993;38:1137–1146.CrossRef Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 1993;38:1137–1146.CrossRef
17.
go back to reference Langholz E, Munkholm P, Davidsen M et al. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol 1996;31:260–266.CrossRef Langholz E, Munkholm P, Davidsen M et al. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol 1996;31:260–266.CrossRef
18.
go back to reference Eleftheriadis N, Lambrecht G, D’Haens G et al. Maintenance therapy for ulcerative colitis has no impact on changes in the extent of ulcerative colitis. J Crohns Colitis 2007;1:21–27.CrossRef Eleftheriadis N, Lambrecht G, D’Haens G et al. Maintenance therapy for ulcerative colitis has no impact on changes in the extent of ulcerative colitis. J Crohns Colitis 2007;1:21–27.CrossRef
19.
go back to reference Karoui S, Kallel L, Dahmani Z et al. Frequency of proximal colonic extension of distal ulcerative colitis. Tunis Med 2007;85:669–672.PubMed Karoui S, Kallel L, Dahmani Z et al. Frequency of proximal colonic extension of distal ulcerative colitis. Tunis Med 2007;85:669–672.PubMed
20.
go back to reference Fdez-Morera JL, Rodrigo L, López-Vázquez A et al. MHC class I chain-related gene A transmembrane polymorphism modulates the extension of ulcerative colitis. Hum Immunol 2003;64:816–822.CrossRef Fdez-Morera JL, Rodrigo L, López-Vázquez A et al. MHC class I chain-related gene A transmembrane polymorphism modulates the extension of ulcerative colitis. Hum Immunol 2003;64:816–822.CrossRef
21.
go back to reference Ayres RC, Gillen CD, Walmsley RS et al. Progression of ulcerative proctosigmoiditis: incidence and factors influencing progression. Eur J Gastroenterol Hepatol 1996;8:555–558.CrossRef Ayres RC, Gillen CD, Walmsley RS et al. Progression of ulcerative proctosigmoiditis: incidence and factors influencing progression. Eur J Gastroenterol Hepatol 1996;8:555–558.CrossRef
22.
go back to reference Khan N, Trivedi C, Shah Y et al. The natural history of newly diagnosed ulcerative colitis in patients with concomitant primary sclerosing cholangitis. Inflamm Bowel Dis 2018;24:2062–2067.CrossRef Khan N, Trivedi C, Shah Y et al. The natural history of newly diagnosed ulcerative colitis in patients with concomitant primary sclerosing cholangitis. Inflamm Bowel Dis 2018;24:2062–2067.CrossRef
23.
go back to reference Alkim C, Alkim H, Dağli U et al. Extension of ulcerative colitis. Turk J Gastroenterol 2011;22:382–387.CrossRef Alkim C, Alkim H, Dağli U et al. Extension of ulcerative colitis. Turk J Gastroenterol 2011;22:382–387.CrossRef
24.
go back to reference Anzai H, Hata K, Kishikawa J et al. Appendiceal orifice inflammation is associated with proximal extension of disease in patients with ulcerative colitis. Colorectal Dis 2016;18:278–282.CrossRef Anzai H, Hata K, Kishikawa J et al. Appendiceal orifice inflammation is associated with proximal extension of disease in patients with ulcerative colitis. Colorectal Dis 2016;18:278–282.CrossRef
25.
go back to reference Jairath V, Peyrin-Biroulet L, Zou G et al. Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial. Gut 2019;68:1162–1168.CrossRef Jairath V, Peyrin-Biroulet L, Zou G et al. Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial. Gut 2019;68:1162–1168.CrossRef
26.
go back to reference Lobatón T, Bessissow T, Ruiz-Cerulla A et al. Prognostic value of histological activity in patients with ulcerative colitis in deep remission: a prospective multicenter study. United Eur Gastroenterol J 2018;6:765–772.CrossRef Lobatón T, Bessissow T, Ruiz-Cerulla A et al. Prognostic value of histological activity in patients with ulcerative colitis in deep remission: a prospective multicenter study. United Eur Gastroenterol J 2018;6:765–772.CrossRef
27.
go back to reference Christensen B, Hanauer SB, Erlich J et al. Histologic normalization occurs in ulcerative colitis and is associated with improved clinical outcomes. Clin Gastroenterol Hepatol 2017;15:1557–1564.CrossRef Christensen B, Hanauer SB, Erlich J et al. Histologic normalization occurs in ulcerative colitis and is associated with improved clinical outcomes. Clin Gastroenterol Hepatol 2017;15:1557–1564.CrossRef
28.
go back to reference Chateau T, Feakins R, Marchal-Bressenot A et al. Histological remission in ulcerative colitis: under the microscope is the cure. Am J Gastroenterol 2020;115:179–189.CrossRef Chateau T, Feakins R, Marchal-Bressenot A et al. Histological remission in ulcerative colitis: under the microscope is the cure. Am J Gastroenterol 2020;115:179–189.CrossRef
29.
go back to reference Reinisch W, Reinink AR, Higgins PDR. Factors associated with poor outcomes in adults with newly diagnosed ulcerative colitis. Clin Gastroenterol Hepatol 2015;13:635–642.CrossRef Reinisch W, Reinink AR, Higgins PDR. Factors associated with poor outcomes in adults with newly diagnosed ulcerative colitis. Clin Gastroenterol Hepatol 2015;13:635–642.CrossRef
30.
go back to reference Höie O, Wolters F, Riis L et al. Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a Europeanwide population-based cohort. Am J Gastroenterol 2007;102:1692–1701.CrossRef Höie O, Wolters F, Riis L et al. Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a Europeanwide population-based cohort. Am J Gastroenterol 2007;102:1692–1701.CrossRef
31.
go back to reference Godet PG, May GR, Sutherland LR. Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut 1995;37:668–673.CrossRef Godet PG, May GR, Sutherland LR. Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut 1995;37:668–673.CrossRef
Metadata
Title
Baseline Histological Findings Do Not Predict the Risk of Subsequent Extension in Patients with Limited Ulcerative Colitis
Authors
Yansheng Hao
Clara Yzet
Russell B. McBride
Aryeh Stock
Elisa Tiratterra
Antonietta D’Errico
Andrea Belluzzi
Eleonora Scaioli
Paolo Gionchetti
Giulia Roda
Ryan Ungaro
Jean-Frederic Colombel
Noam Harpaz
Huaibin Mabel Ko
Publication date
01-04-2022
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-06970-y

Other articles of this Issue 4/2022

Digestive Diseases and Sciences 4/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.